Chemical Compound

B-[(1S)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic Acid; bortezomib diastereomer (S,S) (USP)

CAS Registry Number 1132709-14-8
B-[(1S)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic Acid; bortezomib diastereomer (S,S) (USP) 结构式
Primary record

B-[(1S)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic Acid; bortezomib diastereomer (S,S) (USP)

库存
4,324 克
纯度
99.3 %
CAS
1132709-14-8

化合物标识与属性

CAS
1132709-14-8
PubChem CID
24871309
SMILES
B([C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
Canonical SMILES
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O

名称与同义词

  • (1S,2S)-Bortezomib
  • Bortezomib
  • 1132709-14-8
  • Bortezomib 10mg
  • Bortezomib Impurity 6
  • ((S)-3-Methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid
  • PQ2SUA6Q7G
  • Bortezomib USP Impurity G
  • Bortezomib, (1S,2S)-
  • Bortezomib (S,S)-Diastereomer
  • GXJABQQUPOEUTA-DOTOQJQBSA-N
  • CHEMBL524664
  • orb1310069
  • SCHEMBL8035134
  • C19H25BN4O4
  • DTXSID30647765
  • cid_24871309
  • MFCD05260688
  • BDBM200228
  • HMS2089J16
  • EBC-02048
  • AKOS016844850
  • ZINC169897614
  • NCGC00181022-01
  • NCGC00181022-02
  • NCGC00181022-03
  • NCGC00181022-04
  • NCGC00181022-05
  • DA-59469
  • MS-26312
  • AB01275474-01
  • HY-135396
  • CS-0112392
  • (1S,2S)-BORTEZOMIB (REFERENCE GRADE)
  • J1.066.189G
  • [(1S)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid
  • EN300-716376
  • G13311
  • 179B697
  • SR-05000001469
  • A1009660
  • SR-05000001469-2
  • [(1S)-3-methyl-1-[(2S)-3-phenyl-2-[(pyrazin-2-yl)formamido]propanamido]butyl]boronic acid
  • B0103-467636
  • 179324-69-7
  • [(1S)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazin-2-ylcarbonylamino)propanoyl]amino]butyl]boronic acid
  • N-[(1S)-1-Borono-3-methylbutyl]-Nalpha-(pyrazine-2-carbonyl)-L-phenylalaninamide
  • Nalpha-(Pyrazine-2-ylcarbonyl)-N-[(S)-1-dihydroxyboryl-3-methylbutyl]-L-phenylalaninamide
  • [(1S)-1-[[(2S)-3-phenyl-2-[(pyrazine-2-carbonyl)amino]-1-oxopropyl]amino]-3-methylbutyl]boronic acid
  • B-[(1S)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic Acid
  • B-[(1S)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic Acid; bortezomib diastereomer (S,S) (USP)
  • B-[(1S)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid
  • Boronic acid, B-[(1S)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-
  • FN3
  • N-[(S)-1-(Dihydroxyboryl)-3-methylbutyl]-Nalpha-[(pyrazin-2-yl)carbonyl]-L-phenylalaninamide